Tech Company Financing Transactions

Castle Biosciences Funding Round

Industry Ventures, HealthQuest Capital and Mountain Group Capital participated in a $11.7 million Series F funding round for Castle Biosciences. This VC investment round was announced on 7/27/2015.

Transaction Overview

Company Name
Castle Biosciences
Announced On
7/27/2015
Transaction Type
Venture Equity
Amount
$11,700,000
Round
Series F
Investors

Industry Ventures (Lead Investor) (Victor Hwang)

HealthQuest Capital (Garheng Kong)

Mountain Group Capital

Proceeds Purpose
The funding will be used to accelerate the growth in clinical adoption of the Company's gene test for identifying metastatic risk in early stage cutaneous melanoma, DecisionDx-Melanoma, and its other tests designed to improve cancer care.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3737 N. 7th St. 160
Phoenix, AZ 85014
USA
Phone
(866) 788-9007
Website
www.castlebiosciences.com
Email Address
[email protected]
Overview
Castle Biosciences (Nasdaq: CSTL) offers diagnostic tests that provide actionable, tumor-specific information for improved treatment decisions and patient outcomes.
Profile
Castle Biosciences LinkedIn Company Profile
Social Media
Castle Biosciences Company Twitter Account
Company News
Castle Biosciences News
Facebook
Castle Biosciences on Facebook
YouTube
Castle Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Derek Maetzold
  Derek Maetzold LinkedIn Profile  Derek Maetzold Twitter Account  Derek Maetzold News  Derek Maetzold on Facebook
Chief Financial Officer
Frank Stokes
  Frank Stokes LinkedIn Profile  Frank Stokes Twitter Account  Frank Stokes News  Frank Stokes on Facebook
Chief Medical Officer
Federico Monzon
  Federico Monzon LinkedIn Profile  Federico Monzon Twitter Account  Federico Monzon News  Federico Monzon on Facebook
Chief Operating Officer
Bernhard Spiess
  Bernhard Spiess LinkedIn Profile  Bernhard Spiess Twitter Account  Bernhard Spiess News  Bernhard Spiess on Facebook
VP - Operations
Kristen Oelschlager
  Kristen Oelschlager LinkedIn Profile  Kristen Oelschlager Twitter Account  Kristen Oelschlager News  Kristen Oelschlager on Facebook
VP - R & D
Robert Cook
  Robert Cook LinkedIn Profile  Robert Cook Twitter Account  Robert Cook News  Robert Cook on Facebook
VP - Sales
Toby Juvenal
  Toby Juvenal LinkedIn Profile  Toby Juvenal Twitter Account  Toby Juvenal News  Toby Juvenal on Facebook

 

 

Browse more venture capital transactions:

Prev: 7/27/2015: eFFECTOR Therapeutics venture capital transaction
Next: 7/27/2015: AdAgility venture capital transaction

 

Share this article

 

Where The Data Comes From

We report on all VC transactions involving tech companies. All VC database entries on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.